Cipla is currently trading at Rs. 1411.40, up by 3.85 points or 0.27% from its previous closing o...
Sanofi India is currently trading at Rs. 8049.00, up by 338.15 points or 4.39% from its previous ...
Select healthcare stocks witnessed gains on the BSE during the afternoon deals. Ajanta Pharma, Ab...
U.S. drugmaker Eli Lilly expects to launch Mounjaro, its blockbuster diabetes drug and wildly pop...
Indian drugmakers aiming to grab a slice of the burgeoning weight-loss treatment sales pie,...
gRevlimid bigger; others delayed Results ahead of estimates, driven primarily b...
Cipla is currently trading at Rs. 1438.20, up by 15.35 points or 1.08% from its previous closing ...
CIPLA is currently trading at ?1450, moving within the range of 1420 to 1450 and showing signs of...
Indian generic drugmaker Zydus Lifesciences reported a bigger-than-expected rise in third-quarter...
Cipla is currently trading at Rs. 1442.15, up by 3.10 points or 0.22% from its previous closing o...
India's J B Chemicals and Pharmaceuticals reported its sixth straight quarter of profit...
Cipla is currently trading at Rs. 1413.60, up by 22.15 points or 1.59% from its previous closing ...
* North America Business: In Q3FY24, North America recorded the revenue of INR 19,160mn (US$ 2...
Striving for sustainable growth beyond FY24 A robust ANDA pipeline to overcome price erosion a...
Indian generic drugmaker Cipla on Monday reported its third-quarter profit above analysts expecta...
Cipla Ltd Buy Cipla Ltd CMP 1322.95; Range 1320-1325 SL 1280; Target&n...
The US generics market and branded markets have seen significant growth, with moderate raw materi...
CIPLA Ltd. * Pharma sector trading strong around life highs and CIPLA is trading insync. * ...
Cipla Ltd * Pharma sector trading strong around life highs and CIPLA is trading insync. ...
Indian biopharmaceutical company Biocon reported a smaller-than-expected quarterly profit on Frid...
CIPLA Ltd * Seeing recovery in the pharma pack and Cipla is trading in line with trend. ...
Cipla is currently trading at Rs. 1211.55, up by 7.50 points or 0.62% from its previous closing o...
NA/DF drives improved profitability EBITDA margin guidance further raised to 23-24% for FY24 ...
Cipla is currently trading at Rs. 1178.10, up by 27.95 points or 2.43% from its previous closing ...
An analysis for the month of November indicated that the Nifty had closed in the green on five oc...
Kedar Upadhye has been appointed as the new Chief Financial Officer (CFO) of Biocon Biologics whi...
Cipla is currently trading at Rs. 1175.95, up by 12.15 points or 1.04% from its previous closing ...
Cipla Ltd.* Pharma pack is witnessing profit booking and CIPLA is trading insync. * It has regi...
India's Torrent Pharmaceuticals is in talks with private equity funds CVC Capital Partners and Ba...
Expanding portfolio by adding Pepitides/Injectable/Inhalers* During FY13-FY23, CIPLA?s US sales c...